Project Grant R01DE034985

Award Date 7/1/25
Completion Date 6/30/30
Dollars Obligated $645K
Federal Grant Program
93.121
Assistance Type
Project Grant
Place of Performance
Arizona, USA
Similar Awards
The National Institute of Dental and Craniofacial Research (NIDCR) awarded a $714,711 Project Grant under the Oral Diseases and Disorders Research program (CFDA 93.121) to the Icahn School of Medicine at Mount Sinai. The 5-year grant, which commenced on July 1, 2025, aims to investigate mechanisms that can specifically protect or regenerate salivary glands without benefiting cancer growth following radiation therapy. The research team developed a scalable gene targeting system to screen over...
This federal Project Grant award from the National Institute of Dental and Craniofacial Research (NIDCR), part of the Oral Diseases and Disorders Research program (CFDA 93.121), provides $628,965.00 to the Icahn School of Medicine at Mount Sinai over a 5-year period from May 1, 2025 to April 30, 2030. The funding supports research to elucidate how immune cells, specifically tissue-resident macrophages, regulate the coordinated processes of salivary gland development and differentiation. The...
This Project Grant award from the National Institute of Dental and Craniofacial Research (NIDCR), under the Oral Diseases and Disorders Research program (CFDA 93.121), is providing $409,960.00 to Texas A&M University System Health Science Center to develop a human salivary gland-on-a-chip model. The goal is to create a platform that can faithfully replicate normal salivary gland function as well as model the effects of radiation-induced damage, in order to improve drug development efforts...
This $622,744 Project Grant awarded by the National Institute of Dental and Craniofacial Research (NIDCR) under the Oral Diseases and Disorders Research federal grant program (CFDA 93.121) supports research to investigate the role of the TRPM2 calcium channel in the development of radiation-induced oral mucositis (RIOM). The University of Texas Health Science Center at San Antonio is conducting this 5-year research project to understand how TRPM2 activation and calcium signaling contribute to...
The National Institute of Dental and Craniofacial Research (NIDCR) awarded a $1,403,398 Project Grant under the Oral Diseases and Disorders Research program (CFDA 93.121) to The General Hospital Corporation (Massachusetts General Hospital) to conduct research on precision imaging approaches for understanding the spatial regulators of the hybrid epithelial/mesenchymal state in head and neck cancer. The project aims to utilize advanced imaging techniques to investigate how the hybrid...
This Project Grant award from the National Institute of Dental and Craniofacial Research (NIDCR), under the Oral Diseases and Disorders Research federal grant program (CFDA 93.121), is providing $100,676 to the Icahn School of Medicine at Mount Sinai to conduct research on defining the role of tissue-resident macrophages during salivary gland morphogenesis. The research aims to determine the functional contribution of these macrophages to salivary gland development and characterize their role in...
The National Institute of Dental and Craniofacial Research (NIDCR) awarded a $808,264 Project Grant under the Oral Diseases and Disorders Research (CFDA 93.121) federal grant program to The Medical University of South Carolina. The grant aims to elucidate the mechanisms underlying filopodia-mediated intracellular uptake of a cell-penetrating peptide (RD3AD) complex carrying small interfering RNAs (siRNAs), and to determine its ability to target and deliver siRNAs to migrating/invading oral...
The federal Project Grant award R00DE032363, provided by the National Institute of Dental and Craniofacial Research (NIDCR) under the Oral Diseases and Disorders Research (CFDA 93.121) program, will fund research to explore the role of tuft cells in salivary gland immunity. The $608,632.33 award, spanning from Sep 1, 2024 to Mar 31, 2028, will support the following key objectives: (1) investigating tuft cell distribution and function in salivary gland epithelium, (2) determining tuft cell...
This Project Grant award from the National Institute of Dental and Craniofacial Research (NIDCR), under the Oral Diseases and Disorders Research federal grant program (CFDA 93.121), provides $248,750.00 to the ADA Forsyth Institute, Inc. (The Forsyth Institute) to investigate the role of cellular senescence in salivary gland dysfunction associated with Sjögren's syndrome. The research aims to determine the impact of cellular senescence on Sjögren's syndrome-related xerostomia (dry mouth) and...
This Project Grant award from the National Institute of Dental and Craniofacial Research (NIDCR), under the Oral Diseases and Disorders Research program (CFDA 93.121), aims to determine the function of TRP-positive trigeminal sensory neurons innervating the submandibular salivary glands. The $174,418 award to the Regents of the University of Michigan will support research to understand how this direct sensory innervation provides feedback to modulate the salivary system, with the goal of...

The National Institute of Dental and Craniofacial Research (NIDCR) awarded a $644,970 Project Grant under the Oral Diseases and Disorders Research (CFDA 93.121) program to the University of Arizona. The grant will fund research over a 5-year period from July 1, 2025 to June 30, 2030 to investigate the role of immune-epithelial interactions in restoring salivary gland function after radiation therapy for head and neck cancer. The research aims to develop a kinetic model of the metabolic phenotype of infiltrating immune populations and how they impact epithelial regeneration and repair in damaged salivary glands. The outcomes will include characterizing the immunometabolic profile of T cells following radiation, evaluating the effect of modulating T cell metabolism on repairing damaged glands, identifying the specific immune cell populations surrounding damaged epithelial cells, and assessing the impact of immune cell metabolism on the ability of metformin to reverse salivary gland dysfunction.

Generated 8/5/25, 4:56 AM